EGC is leading a collaborative national effort to raise awareness of a new tax law that requires capitalization of Research & Experimentation (R&E) expenses and detrimentally impacts companies conducting critical scientific work. Our letter to Congress has been signed by 501 companies and individuals from 48 states and DC, and is available here. We encourage […]
EGC has released our 2023 US Non-Dilutive Funding Outlook. Click here to view the report.
After a 2 year hiatus, EGC was thrilled to host our annual Holiday Party at the Bridge Club in downtown Raleigh. Our CEO, Dr. Eva Garland, spoke about EGC’s many successes in 2022, including: – EGC’s customer base growing to over 2,000 clients across 50 states and 12 countries – Our largest grant to-date, $100M, […]
The UC Davis Venture Catalyst group will host EGC for a SBIR/STTR Grant Workshop, on October 16, 2018 from 5:30pm-8:00pm. Dr. Eva Garland and Dr. Angela Pollard will be leading the workshop, which will cover all aspects of how to strategically approach obtaining funding from the […]
EGC has been recognized by Inc. magazine as one of America’s 5000 fastest-growing companies. We are thrilled to be part of this prestigious list, and we look forward to continuing to help our clients advance their scientific innovations! Raleigh-based Eva Garland Consulting cracks Inc. 5000 – here’s why